Navigation Links
TOPEX Sells Skin Cancer Business Operations to SENSUS Healthcare
Date:8/18/2010

DANBURY, Conn., Aug. 18 /PRNewswire/ -- TOPEX, Inc. announces the sale of its skin cancer business operations to SENSUS Healthcare, LLC for its low energy SRT 100 superficial radiotherapy treatment system. Since TOPEX received FDA approval during 2007, many systems have been operating worldwide at hospital radiation oncology centers, dermatology and veterinary oncology practices for the treatment of skin cancer. The low energy superficial radiotherapy system provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers, especially primary lesions requiring difficult or extensive surgery with sensitive structures in the head and neck regions -- the fold in the nose, eyelids, lips, corner of the mouth, and the lining of the ear that would otherwise lead to a less than desirable cosmetic outcome. This treatment procedure does not require the use of anesthetics and eliminates the need for skin grafting.

Anthony Pellegrino, TOPEX founder and CEO, stated, "SENSUS Healthcare brings together a highly skilled team of technical sales and marketing professionals for expanding superficial radiotherapy clinical use and business development in the global marketplace."

Joe Sardano, CEO, SENSUS Healthcare stated, "Mr. Pellegrino is recognized for making good technologies better. Physicians and patients alike deserve to have better choices for their treatment. Superficial Radiotherapy provides a non invasive choice to treat skin cancer with appropriate dose levels and proven clinical high cure rates. SENSUS is privileged to offer this technology as well as other products and services to this market segment."

The incidence of skin cancer has steadily increased over the past 75 years. During the 1930s, 1 in 1500 developed skin cancer. In 1960, the rate had risen to 1 in 600 and in 2000, the rate increased to 1 in 66. The National Cancer Institute estimates that 1 out of 5 is now at risk for developing some form of skin cancer during their lifetime. Increased exposure to the sun without skin protection and a decreasing natural ozone layer are cited as the chief causes of this increase. It is estimated that up to 1.3M new skin cancer cases are diagnosed annually in the United States and over 2.5M worldwide. This is projected to increase at a rate of 4% each year.

About TOPEX, Inc. - TOPEX is a technology company focused on the design, manufacture and marketing of products using proprietary strengths in x-ray product design. The company is privately held and based in Danbury, CT.

About SENSUS Healthcare - Taking new aim at skin cancer, SENSUS Healthcare is focused on the design, manufacture and marketing of products and services that incorporate proprietary mobile X-ray technology for cost-effective, non-invasive treatment of non-melanoma skin cancers. The signature SENSUS Healthcare product, the SRT-100, meets stringent safety requirements set by the FDA, UL and ISO/CE Mark certification. Based in Boca Raton, Fla., SENSUS employs best-practice standard operational procedures to ensure quality control, high-grade customer support, optimized success in field operations, and product reliability. For more information, visit www.sensushealthcare.com.


'/>"/>
SOURCE TOPEX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Foundation Venture Capital Group Sells Interest in Longevica Pharmaceuticals
2. Graymark Healthcare Sells Record Number of CPAP Devices in Q2 2010
3. ScandiDos Sells 100th Delta4(R) PT Unit as Adoption of Rotational Therapy Cancer Treatment Increases
4. Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010
5. Ferring Pharmaceuticals FIRMAGON® Joins Race to End Prostate Cancer as Official Sponsor of the Great Prostate Cancer Challenge / Dash for Dad
6. Islanders and Tourists with Brain Cancer to Benefit from Hawaiian Centers Installment of Elektas Leksell Gamma Knife Perfexion
7. OvaGene Oncology Joins The Gynecologic Oncology Group (GOG) Industry Collaboration Team to Advance Gynecologic Cancer Research
8. Siteman Cancer Center at Barnes-Jewish and Washington University to Receive First ViewRay Radiation Therapy System
9. Electronic Brachytherapy Offers Safe, Convenient Alternative to Traditional Therapy Across Broad Range of Cancers
10. Prostate Cancer Patients Benefit from New Zealand Centers Adoption of Elekta VMAT Radiotherapy Technique
11. Moffitt Cancer Center and CvergenX, Inc. Sign Licensing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):